DA approval of a psychedelic therapy now looks likely. VETS policy director Logan Davidson argues the harder fight starts the day after: REMS rules, insurance codes, VA formularies, and a workforce that was short before this therapy existed.

The post The Problems We Will Be Lucky to Have appeared first on Psychedelics Today.

Previous articlePα+ Psychedelic Bulletin #234: Psychedelics After the Midterms; FDA Answers House Psychedelics Caucus; ICER to Review Compass’ Psilocybin; Terran v. Compass Gets Trial Date